Sweden · Delayed Price · Currency is SEK Bioextrax AB Statistics
Total Valuation
Bioextrax AB has a market cap or net worth of SEK 113.29 million. The enterprise value is 105.90 million.
| Market Cap | 113.29M |
| Enterprise Value | 105.90M |
Important Dates
The next estimated earnings date is Friday, November 20, 2026.
| Earnings Date | Nov 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Bioextrax AB has 47.60 million shares outstanding. The number of shares has increased by 13.87% in one year.
| Current Share Class | 47.60M |
| Shares Outstanding | 47.60M |
| Shares Change (YoY) | +13.87% |
| Shares Change (QoQ) | +6.69% |
| Owned by Insiders (%) | 19.62% |
| Owned by Institutions (%) | 16.44% |
| Float | 37.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 110.64 |
| PB Ratio | 9.46 |
| P/TBV Ratio | 9.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 103.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.53
| Current Ratio | 3.53 |
| Quick Ratio | 3.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18,681.00 |
Financial Efficiency
Return on equity (ROE) is -124.00% and return on invested capital (ROIC) is -77.96%.
| Return on Equity (ROE) | -124.00% |
| Return on Assets (ROA) | -67.59% |
| Return on Invested Capital (ROIC) | -77.96% |
| Return on Capital Employed (ROCE) | -155.93% |
| Weighted Average Cost of Capital (WACC) | 12.43% |
| Revenue Per Employee | 73,143 |
| Profits Per Employee | -1.33M |
| Employee Count | 14 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -32.53% in the last 52 weeks. The beta is 1.49, so Bioextrax AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.49 |
| 52-Week Price Change | -32.53% |
| 50-Day Moving Average | 2.49 |
| 200-Day Moving Average | 2.48 |
| Relative Strength Index (RSI) | 44.15 |
| Average Volume (20 Days) | 88,283 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bioextrax AB had revenue of SEK 1.02 million and -18.57 million in losses. Loss per share was -0.43.
| Revenue | 1.02M |
| Gross Profit | -34,000 |
| Operating Income | -18.68M |
| Pretax Income | -18.57M |
| Net Income | -18.57M |
| EBITDA | -17.63M |
| EBIT | -18.68M |
| Loss Per Share | -0.43 |
Balance Sheet
The company has 7.39 million in cash and no debt, with a net cash position of 7.39 million or 0.16 per share.
| Cash & Cash Equivalents | 7.39M |
| Total Debt | n/a |
| Net Cash | 7.39M |
| Net Cash Per Share | 0.16 |
| Equity (Book Value) | 11.98M |
| Book Value Per Share | 0.25 |
| Working Capital | 6.33M |
Cash Flow
In the last 12 months, operating cash flow was -15.66 million and capital expenditures -323,000, giving a free cash flow of -15.98 million.
| Operating Cash Flow | -15.66M |
| Capital Expenditures | -323,000 |
| Depreciation & Amortization | 1.05M |
| Net Borrowing | n/a |
| Free Cash Flow | -15.98M |
| FCF Per Share | -0.34 |
Margins
| Gross Margin | -3.32% |
| Operating Margin | -1,824.32% |
| Pretax Margin | -1,813.48% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Bioextrax AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.87% |
| Shareholder Yield | -13.87% |
| Earnings Yield | -16.39% |
| FCF Yield | -14.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 22, 2021. It was a forward split with a ratio of 4.
| Last Split Date | Jul 22, 2021 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |